RealNetworks (NASDAQ: RNWK) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.
Volatility & Risk
Get RealNetworks alerts:RealNetworks has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.
Dividends
Amdocs pays an annual dividend of $1.00 per share and has a dividend yield of 1.4%. RealNetworks does not pay a dividend. Amdocs pays out 28.2% of its earnings in the form of a dividend.
Valuation & Earnings
This table compares RealNetworks and Amdocs’ revenue, earnings per share (EPS) and valuation.
Hot Undervalued Stocks To Own Right Now: MyoKardia, Inc.(MYOK)
MyoKardia, Inc., incorporated under the laws of the State of Delaware in June 2012, is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We have used our precision medicine platform to generate an initial pipeline of four therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy--hypertrophic cardiomyopathy, or HCM, and dilated cardiomyopathy, or DCM. We have discovered and advanced our lead product candidate, MYK-461, into Phase 1 clinical development. Advisors' Opinion:
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Myokardia (MYOK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
BidaskClub cut shares of Myokardia (NASDAQ:MYOK) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday morning.
- [By Max Byerly]
Equities researchers at Cantor Fitzgerald assumed coverage on shares of Myokardia (NASDAQ:MYOK) in a note issued to investors on Monday, The Fly reports. The brokerage set an “overweight” rating on the biotechnology company’s stock.
Hot Undervalued Stocks To Own Right Now: EQT Midstream Partners, LP(EQM)
EQT Midstream Partners, LP provides natural gas transmission, storage, and gathering services in southwestern Pennsylvania and northern West Virginia. It owns, operates, acquires, and develops midstream assets in the Appalachian Basin. As of February 4, 2016, the company owned 700 miles and operated an additional 200 miles of interstate pipelines; and owned approximately 1,600 miles of high-and low-pressure gathering lines. It serves local distribution companies, marketers, producers, and commercial and industrial users, as well as natural gas producers. EQT Midstream Services, LLC serves as the general partner of the company. EQT Midstream Partners, LP is headquartered in Pittsburgh, Pennsylvania.
Equitrans Midstream (NYSE:ETRN) and its MLP EQM Midstream Partners (NYSE:EQM) were already on track to deliver significant growth over the next few years due to the expansion projects they have underway. Now, they're bolstering their already strong prospects by spending $1.03 billion for two midstream systems focused on the Marcellus and Utica Shale plays. These transactions will enhance the long-term sustainability and growth prospects of their high-yield dividends, which are currently 8.3% for Equitrans and 10.5% for EQM Midstream. ILLEGAL ACTIVITY WARNING: “California Public Employees Retirement System Has $6.57 Million Holdings in EQM Midstream Partners LP (EQM)” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/4215048/california-public-employees-retirement-system-has-6-57-million-holdings-in-eqm-midstream-partners-lp-eqm.html. EQM Midstream Partners LP (NYSE:EQM) saw unusually large options trading on Thursday. Stock traders acquired 1,708 put options on the company. This represents an increase of approximately 1,439% compared to the average daily volume of 111 put options. We are a technology driven company that aggregates, via the Internet, large volumes of small, individually customized orders for a broad spectrum of print, signage, apparel and similar products. We fulfill those orders with manufacturing capabilities that include Cimpress owned and operated manufacturing facilities and a network of third-party fulfillers to create customized products for customers on-demand. We bring our products to market through a portfolio of focused brands serving the needs of micro, small and medium sized businesses, resellers and consumers. These brands include Vistaprint, our global brand for micro business marketing products and services, as well as brands that we have acquired that serve the needs of various market segments, including resellers, small and medium businesses with differentiated service needs, and consumers purchasing products for themselves and their families. Advisors' Opinion: Shares of Cimpress (NASDAQ:CMPR) declined 19.6% in January, according to data from S&P Global Market Intelligence, after the mass-customization company announced disappointing fiscal second-quarter results. Cimpress (NASDAQ:CMPR) last announced its earnings results on Wednesday, January 30th. The business services provider reported $2.17 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.38 by ($0.21). Cimpress had a return on equity of 58.85% and a net margin of 1.67%. The company had revenue of $825.57 million for the quarter, compared to the consensus estimate of $854.97 million. During the same period last year, the firm posted $0.93 EPS. The company’s revenue was up 8.3% compared to the same quarter last year. Analysts predict that Cimpress NV will post 3.29 EPS for the current year. About Cimpress Cimpress NV (NASDAQ:CMPR) insider Sean Edward Quinn sold 777 shares of the firm’s stock in a transaction on Friday, August 31st. The stock was sold at an average price of $139.40, for a total transaction of $108,313.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Owens-Illinois, Inc., through its subsidiaries, manufactures and sells glass container products primarily in Europe, North America, South America, and the Asia Pacific. The company produces glass containers for beer, ready-to-drink low alcohol refreshers, spirits, wine, food, tea, juice, and pharmaceuticals, as well as for soft drinks and other non-alcoholic beverages, including returnable/refillable glass containers. It serves brewers, wine vintners, distillers, and food producers. The company sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. Owens-Illinois, Inc. was founded in 1903 and is headquartered in Perrysburg, Ohio. JPMorgan Chase & Co. lifted its stake in Owens-Illinois Inc (NYSE:OI) by 19.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 523,606 shares of the industrial products company’s stock after acquiring an additional 85,424 shares during the period. JPMorgan Chase & Co. owned approximately 0.33% of Owens-Illinois worth $9,838,000 at the end of the most recent reporting period. Shares of Owens-Illinois Inc. (NYSE:OI) jumped 9.9% on Friday after activist investor Atlantic Investment Management called for the glass-container specialist to take a number of actions to maximize shareholder value. Tekla Healthcare Investors (the Fund), formerly H&Q Healthcare Investors, incorporated on October 31, 1986, is a registered investment adviser based in Boston, Massachusetts and is currently the investment adviser for three closed-end equity funds, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors and Tekla Life Sciences Investors. The Funds invest in growth equities, both public and private, debt and pooled investment vehicles, in the healthcare and life sciences industries. Tekla Healthcare Investors Tekla Healthcare Investors (HQH) is a diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQH. HQH primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors. Tekla Life Sciences Investors Tekla Life Sciences Investors (HQL) is a diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in the life sciences (including biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management industries. The Fund's objective is to provide long-term capital appreciation through investments in companies in the life sciences industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's asset! s in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors. Tekla Healthcare Opportunities Fund Tekla Healthcare Opportunities Fund (THQ) is a non-diversified closed-end fund traded on the New York Stock Exchange under the ticker THQ. THQ invests primarily in the healthcare industry. The Fund's objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. Bank of Nova Scotia cut its stake in shares of Tekla Healthcare Investors (NYSE:HQH) by 19.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 69,440 shares of the financial services provider’s stock after selling 17,077 shares during the period. Bank of Nova Scotia owned about 0.17% of Tekla Healthcare Investors worth $1,493,000 at the end of the most recent quarter. Tekla Healthcare Investors (NYSE:HQH) announced a quarterly dividend on Monday, August 20th, Wall Street Journal reports. Shareholders of record on Tuesday, August 28th will be given a dividend of 0.47 per share by the financial services provider on Friday, September 28th. This represents a $1.88 dividend on an annualized basis and a yield of 8.29%. The ex-dividend date of this dividend is Monday, August 27th. Performant Financial Corporation provides technology-enabled recovery and related analytics services in the United States. Its services help identify and recover delinquent or defaulted assets and improper payments for government and private clients in various markets. The company offers recovery services primarily to the government-supported student loan industry, including the Department of Education and various guaranty agencies, as well as private financial institutions; and audit and recovery services to identify improper healthcare payments for public and private healthcare markets. It also provides tax recovery services to state and municipal agencies, as well as financial institutions; and risk management advisory services that enable clients to proactively manage loan portfolios and reduce the incidence of defaulted loan assets over time. The company was formerly known as DCS Holdings, Inc. and changed its name to Performant Financial Corporation in 2005. Performant Financial Corporation was founded in 1976 and is headquartered in Livermore, California. News coverage about Performant Financial (NASDAQ:PFMT) has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Performant Financial earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the business services provider an impact score of 48.418433643407 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future. SEA (NYSE: SE) and Performant Financial (NASDAQ:PFMT) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Hot Undervalued Stocks To Own Right Now: Cimpress N.V(CMPR)
Hot Undervalued Stocks To Own Right Now: Owens-Illinois Inc.(OI)
Hot Undervalued Stocks To Own Right Now: Tekla Healthcare Investors(HQH)
Hot Undervalued Stocks To Own Right Now: Performant Financial Corporation(PFMT)
No comments:
Post a Comment